HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transmural healing evaluated by bowel sonography in patients with Crohn's disease on maintenance treatment with biologics.

AbstractBACKGROUND:
Both thiopurines and anti-tumor necrosis factor (TNF) α agents are effective for treating Crohn's disease (CD) as they can induce clinical remission (CR) and mucosal healing (MH) in most patients. Nevertheless, data on transmural healing (TH) induced by thiopurines and anti-TNF-α agents are still lacking. This study aimed to explore the rate of TH evaluated by bowel sonography in patients with CD treated with biologics and immunosuppressors and its correlation with CR and MH.
METHODS:
We performed an observational longitudinal study evaluating TH, CR, and MH in all patients with CD attending our clinic who would complete 2 years of maintenance treatment with biologics or thiopurines. CR and MH were assessed in accordance with current literature, whereas TH was recorded using bowel sonography. All patients underwent endoscopy and bowel sonography before starting treatment and 2 years later.
RESULTS:
The study included 66 patients with CD treated with biologics and 67 patients receiving thiopurines. Finally, TH was present in 17 patients on biologics and only 3 patients treated with thiopurines (25% versus 4%; P < 0.01; odds ratio = 6.2). CR was achieved in 37 patients on biologics and in 34 patients on thiopurines (59.7% versus 53%; P = not significant), whereas MH was more frequent in patients treated with anti-TNF-α agents even though without statistical significance (38% versus 25%; P = not significant).
CONCLUSIONS:
TH can be achieved in approximately 25% of patients with CD treated with anti-TNF-α agents and significantly correlates with MH. Further studies are needed to define the potential role of TH as long-term prognostic factor.
AuthorsFabiana Castiglione, Anna Testa, Matilde Rea, Giovanni Domenico De Palma, Maria Diaferia, Dario Musto, Francesca Sasso, Nicola Caporaso, Antonio Rispo
JournalInflammatory bowel diseases (Inflamm Bowel Dis) Vol. 19 Issue 9 Pg. 1928-34 (Aug 2013) ISSN: 1536-4844 [Electronic] England
PMID23835441 (Publication Type: Journal Article)
Chemical References
  • Biological Products
  • Immunosuppressive Agents
Topics
  • Adolescent
  • Adult
  • Aged
  • Biological Products (therapeutic use)
  • Colonoscopy
  • Crohn Disease (genetics)
  • Female
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Intestines (diagnostic imaging)
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Mucous Membrane (drug effects, pathology)
  • Prognosis
  • Prospective Studies
  • Remission Induction
  • Ultrasonography
  • Wound Healing (drug effects, physiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: